This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-carecosts, as well as on society in the form of lost productivity.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: This study aims to estimate the current and future burden of cardiovascular diseases (CVD) in Turkey.Methods: A burden-of-disease model was developed that included inputs on population growth, prevalence, and incidence of ischemic disease(IHD) and cerebrovascular disease (CeVD), prevalence of modifiable risk factors, mortality rates, and relationship between risk factors and IHD/CeVD.
📊
Key Findings & Data:Direct costs to the public health-care system and indirect costs from lost production due to premature mortality, hospitalizations, disability, and absenteeism were considered.Results: We estimated that in 2016, 3.4 million Turkish adults were living with CVD, including 2.5 million affected by IHD, and 0.9 million by CeVD.This prevalence is projected to increase to 5.4 million by 2035.
💡
Conclusion & Impact:This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-carecosts, as well as on society in the form of lost productivity.
🔬Design:Modeling & Simulation
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters
Özet
Objective: This study aims to estimate the current and future burden of cardiovascular diseases (CVD) in Turkey.Methods: A burden-of-disease model was developed that included inputs on population growth, prevalence, and incidence of ischemic disease(IHD) and cerebrovascular disease (CeVD), prevalence of modifiable risk factors, mortality rates, and relationship between risk factors and IHD/CeVD. Direct costs to the public health-care system and indirect costs from lost production due to premature mortality, hospitalizations, disability, and absenteeism were considered.Results: We estimated that in 2016, 3.4 million Turkish adults were living with CVD, including 2.5 million affected by IHD, and 0.9 million by CeVD.This prevalence is projected to increase to 5.4 million by 2035. The economic burden of CVD was estimated at US$10.2 billion in 2016, projectedto increase twofold to US$19.4 billion by 2035.Conclusion: Our study confirms that the current burden of CVD is significant, and that it is projected to increase at a steep rate over the next twodecades. This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-carecosts, as well as on society in the form of lost productivity.
🔖
Cite This Article
BALBAY, Y., ARPIN, I. G., MALHAN, S., ÖKSÜZ, M. E., SUTHERLAND, G., DOBRESCU, A., VILLA, G., ERTUĞRUL, G., HABIB, M. (2018). Modeling the burden of cardiovascular disease in Turkey. The Anatolian Journal of Cardiology, Cilt: 20 - Sayı: 4, 235–240. https://ajindex.com/articles/365287
World Health Organization. Cardiovascular Diseases. 2015; Accessed February 22, 2016.
Institute for Health Metrics and Evaluation. GBD Profile: Turkey 2010
Dinç G, Sözmen K, Gerçeklioğlu G, Arık H, Critchley J, Unal B. Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008. BMC Public Health 2013; 13: 896
World Health Organization. Estimated DALYs ('000) by cause, sex and WHO Member State. Accessed August 30, 2017. http://www.who.int/ healthinfo/global_burden_disease/estimates/en/index2.html
D'Addato AV, Vignoli V, Yavuz, S. Towards smaller family size in Egypt, Morocco and Turkey: overall change over time or socio-economic compositional effect? Rostock; 2007
Carter S, Taylor D, Kanavos P, Grimaccia F, Tordrup D, Tatar M. Transforming Health in Turkey: 21st Century Opportunities. UCL School of Pharmacy 2012; 1-23
Sozmen K, Unal B. Socioeconomic Inequalities in Non-Communicable Diseases and Self Assessed Health in Turkey. Iran J Public Health 2014; 43: 736-48
Ünal B, Ergör G, Dinç Horasan G, Kalaça, S, Sözmen, K. Chronic Diseases and Risk Factors Survey in Turkey. Ankara: Anıl Matbaa Ltd. Şti 2013; 69-89
Arıcı M, Birdane A, Güler K, Yıldız BO, Altun B, Ertürk S, et al. Turkish Hypertension Consensus Report. Turk Kardiyol Dern Ars 2015; 43: 402-9
Satman I. TURDEP-II Sonuçları. 2011
Institute of Medicine. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health: Washington, DC: The National Academies Press; 2010
Checkoway H, Pearce N, Kriebel D. Research Methods in Occupational Epidemiology. Oxford University Press; New York 2004
The World Bank. Health Nutrition and Population Statistics: Population estimates and projections. Accessed July 15, 2016. http:// databank.worldbank.org/data/reports.aspx?source=Health%20Nutrition%20and%20Population%20Statistics:%20Population%20estimates%20and%20projections
Onat A, Senocak MS, Surdum-Avci G, Ornek E. Prevalence of coronary heart disease in Turkish adults. Int J Cardiol 1993; 39: 23-31
Ozturk Y, Demir C, Gursoy K, Koselerli R. Analysis of Stroke Statistics In Turkey. ISPOR 18th Annual European Congress Research Abstracts Research Abstracts 2015; 18: A402